Emergency No
24/7 Support
E-mail
1780034537_Dr_Suhas[1].jfif

Contact Info

Hospital No.
Prior Appointment

Qualifications

 DM – Medical Oncology, MD – General Medicine, MBBS

Specialization / Special Interests

 Medical Oncology | Hemato-Oncology

 Dr. Suhas Vilasrao Aagre is a highly skilled Medical Oncologist and Hemato-Oncologist with over 13 years of overall clinical experience, including more than 6 years as a specialist in cancer care. He specializes in the diagnosis and treatment of solid tumors, blood cancers, chemotherapy, immunotherapy, targeted therapy, and comprehensive oncology care.


 He completed his DM in Medical Oncology from the prestigious Gujarat Cancer & Research Institute (GCRI), Ahmedabad, and has extensive experience in managing complex oncology and hematology cases. Dr. Aagre is actively involved in clinical research, academic teaching, and advanced cancer treatment protocols.

He has authored and published multiple research papers in national and international medical journals on rare oncological disorders and hematological conditions. He has also served as Principal Investigator and Co-Investigator in various international clinical trials related to lung cancer and advanced oncology therapies.

Dr. Aagre has participated in numerous national and international oncology conferences and has contributed actively to academic and scientific programs in the field of cancer care.


  • Secured Second Rank in DM Examinations under Gujarat University

  • Winner of Best Poster Award at National Breast Conference, Ahmedabad (2014)

  • Principal Investigator and Co-Investigator in international oncology clinical trials

  • Extensive academic and teaching experience in Oncology and Internal Medicine   

  • Published multiple research papers in reputed national and international medical journals

  • Research publications focused on rare oncological and hematological case studies

  • Presented academic work in oncology conferences and scientific meetings

  • Active contributor to clinical oncology research and advanced cancer treatment studies